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Host iron status and iron supplementation
mediate susceptibility to erythrocytic stage
Plasmodium falciparum
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Iron deﬁciency and malaria have similar global distributions, and frequently co-exist
in pregnant women and young children. Where both conditions are prevalent, iron
supplementation is complicated by observations that iron deﬁciency anaemia protects against
falciparum malaria, and that iron supplements increase susceptibility to clinically signiﬁcant
malaria, but the mechanisms remain obscure. Here, using an in vitro parasite culture system
with erythrocytes from iron-deﬁcient and replete human donors, we demonstrate that
Plasmodium falciparum infects iron-deﬁcient erythrocytes less efﬁciently. In addition, owing
to merozoite preference for young erythrocytes, iron supplementation of iron-deﬁcient
individuals reverses the protective effects of iron deﬁciency. Our results provide experimental
validation of ﬁeld observations reporting protective effects of iron deﬁciency and harmful
effects of iron administration on human malaria susceptibility. Because recovery from
anaemia requires transient reticulocytosis, our ﬁndings imply that in malarious regions iron
supplementation should be accompanied by effective measures to prevent falciparum
malaria.
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T
he interactions between falciparum malaria and iron
deﬁciency anaemia (IDA) are complex and bi-directional.
Malaria causes acute anaemia by destroying both infected
and uninfected red blood cells (RBCs)1, whereas persistent
sub-clinical infection causes a milder anaemia of infection by
blocking iron recycling to the bone marrow2. Conversely, once
established, IDA protects both pregnant women3–5 and
children6–8 from malaria. In addition, supplemental iron, given
alone or in combination with other micronutrients, predisposes
children to malaria8,9 and other serious adverse outcomes10.
Iron homeostasis has been implicated in regulating liver
stage P. falciparum infection; in murine studies, erythrocytic
stage malaria infection initiates hepcidin-mediated hepatic
hypoferremia, which blocks superinfections by sporozoites from
competing plasmodial strains11. Mathematical modelling suggests
that this can explain the low levels of superinfections in young
children11, but this mechanism cannot account for observed
reductions in the risk of primary malaria infection in children
with IDA. It has also been speculated that transient peaks in non-
transferrin-bound iron caused by administration of highly
absorbable iron supplements12 could promote intra-erythrocytic
parasite growth13 or bacterial septicemia (a common cause of
death in malaria patients14–16) but deﬁnitive evidence is absent.
As iron deﬁciency and iron supplementation of iron deﬁcient
individuals profoundly alters erythropoiesis, RBC physiology, and
RBC population structure, we hypothesized that iron deﬁciency
and iron supplementation directly impact the disease causing
erythrocytic stage of P. falciparum infection. In our investigations,
we minimize the confounding factors that have complicated prior
ﬁeld studies of the relationship between host iron status, iron
supplementation and falciparum malaria by utilizing an in vitro
system with freshly isolated RBCs from donors with well-deﬁned,
physiologic iron states recruited through our US-based hospital
clinic. This approach eliminated the inﬂuence of acquired and
innate immunity to malaria, haemoglobinopathies and concur-
rent inﬂammation. Our study reveals that RBCs from donors with
IDA confer malaria protection by impairing P. falciparum
invasion and intra-erythrocyte propagation. This protective effect
was reversed when donors with IDA received iron supplementa-
tion. We go on to show that when iron-deﬁcient RBCs are
replaced with iron-replete (IR) RBCs in vitro (as occurs in
individuals with IDA following iron supplementation) the
susceptibility to P. falciparum infection is increased. These
ﬁndings support well-described clinical patterns of differential
susceptibility to malaria. Taken together, they indicate that
therapeutic iron supplementation conspires with host iron status
to mediate host RBC susceptibility to malaria infection by altering
the dynamic structure of the host’s RBC population.
Results
Malaria growth is reduced in RBCs from individuals with IDA.
To determine the effect of IDA on the growth of erythrocytic
stage P. falciparum, we enrolled donors with and without IDA
from a non-malaria endemic area through our US-based hospital
clinic. Donors were classiﬁed as IR (haemoglobin (Hgb)
411 g dl 1, mean corpuscular volume (MCV) 480 fL, ferritin
412 ngml 1) or as IDA (Hgb o11 g dl 1, MCV o80 fL, fer-
ritin o12 ngml 1) (Table 1). Non-anaemic donors with low-
iron stores (Hgb 411 g dl 1, ferritin o12 ngml 1) were
excluded. P. falciparum (strains 3D7, Dd2 and FCR3-FMG) were
grown in either RBCs from the IR (n¼ 10) or IDA (n¼ 7) donors
in up to three consecutive 96 h growth assays (Supplementary
Fig. 1). We observed that parasite growth rates were reduced in
RBCs from IDA donors as compared with growth in RBCs from
IR donors by 48.8% (standard deviation (s.d.)±23.9), 34.3%
(s.d.±22.2) and 50.0% (s.d.±20.4) for strains 3D7, Dd2 and
FCR3-FMG, respectively (Fig. 1a). These ﬁndings clearly show
that P. falciparum propagation is reduced within RBCs from IDA
individuals, but that variability may exist in the degree to which
different P. falciparum isolates are affected by IDA.
Malaria growth is increased in RBCs from iron-supplemented
donors. Given ﬁeld evidence that supplementation of children
with 12.5mg of iron (1–1.5mg kg 1) and 50 ng of folic acid may
potentiate the risk of malaria9, we next investigated the effects of
Table 1 | Iron parameters and values of study participants.
Variable Normal
range
IDA (N¼ 7) IDAþ Fe
(N¼6)
IR (N¼ 10) IR after 1 month
iron supplementation
(IRþ Fe; N¼4)
IR after 2 months
iron supplementation
(IRþ Fe; N¼4)
White blood cell (x109 per l) 4.5–11.0 4.84 (1.78) 4.45 (1.15) 6.40 (1.61) 6.30 (1.41) 6.20 (1.12)
Red blood cell ( 1012 per l) 4.0–5.2 3.96 (0.60) 3.42 (0.35) 4.78 (0.52) 4.94 (0.52) 4.91 (0.39)
Haemoglobin (g dl 1) 12.0–16.0 8.20 (1.56) 8.73 (1.23) 14.60 (1.40) 14.90 (0.57) 14.63 (0.53)
Haematocrit (%) 36.0–46.0 28.13 (4.32) 29.11 (4.25) 42.80 (4.31) 43.85 (2.62) 42.88 (2.81)
Mean corpuscular volume (fL) 80.0–100.0 71.20 (6.63) 84.78 (8.28) 89.80 (2.74) 89.67 (4.24) 87.75 (2.50)
Mean corpuscular haemoglobin
(Pg)
26.0–34.0 20.79 (2.54) 25.50 (2.35) 30.70 (0.95) 30.50 (2.12) 30.0 (1.83)
Mean corpuscular haemoglobin
concentration (g dl 1)
31.0–37.0 29.20 (1.50) 30.27 (0.86) 34.20 (0.63) 34.50 (0.71) 34.25 (0.96)
Red cell distribution width (%) 12.0–15.0 17.41 (1.44) 18.13 (2.71) 13.22 (0.85) 13.90 (0.28) 13.20 (0.45)
Mean platelet volume (fL) 7.0–10.0 8.56 (1.05) 8.78 (0.65) 7.63 (0.54) 8.45 (0.92) 8.15 (0.52)
Platelet count ( 109 per l) 150.0–440.0 294.57 (59.70) 344.0 (168.63) 251.80 (36.70) 212.50 (89.80) 256.0 (79.31)
Iron total (mg dl 1) 35.0–165.0 21.60 (10.55) 32.0 (16.79) 103.60 (43.34) 105.75 (32.71) 87.50 (17.99)
Transferrin (mg dl 1) 200.0–380.0 343.60 (74.72) 305.20 (63.55) 264.30 (41.33) 275.0 (29.50) 276.75 (31.83)
Transferrin iron binding
capacity (mg dl 1)
252.0–479.0 438.67 (92.08) 384.60 (80.29) 333.0 (52.20) 346.0 (37.43) 348.75 (40.07)
Transferrin saturation (%) 15.0–50.0 4.71 (3.15) 8.0 (7.45) 31.60 (13.04) 31.0 (9.49) 25.75 (7.63)
Ferritin (ngml 1) 30.0–151.0 5.71 (2.75) 17.17 (25.44) 42.01 (24.28) 46.75 (38.75) 33.33 (18.45)
Reticulocyte (%) 0.5–2.7 1.42 (0.55) 3.52 (1.62) 1.48 (0.48) 2.40 (0.71) 1.40 (0.38)
IDA, iron deﬁciency anaemia; IDAþ Fe, iron deﬁciency anaemia on iron supplementation; IR, iron replete.
Tests were performed by McClendon Clinical Laboratory on samples taken from each donor at the same time points that blood samples were drawn for experiments. Values in the Normal Range column
are the normal or healthy range for each parameter as deﬁned by the McClendon Clinical Laboratory. Numerical values reﬂect the mean value of all individuals in each group and values in parentheses
indicate standard deviation.
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iron supplementation of IDA and IR individuals on in vitro
growth of erythrocytic stage P. falciparum. We ﬁrst collected
RBCs from IDA patients who were receiving iron
supplementation (IDAþ Fe); these individuals met the above
criteria for IDA and were receiving either high-dose oral ferrous
sulfate (60mg elemental iron orally three times per day (9–
12.6mg kg 1)) or intravenous iron (at a dosage determined by
their personal physician using the following equation:
Dose¼ 0.0442 [desired Hgb—observed Hgb] LBWþ [0.26
LBW]). IDAþ Fe group Hgb values ranged from 6.6 to
9.8 g dL 1 and MCV values ranged from 75 to 98 fL.
Additionally reticulocyte counts and red cell distribution width
(RDW) were elevated; and average mean corpuscular
haemaglobin concentration (MCHC), total iron, and ferritin
values were greater than that of the IDA group but still lower than
that of the IR group (Table 1). Together, these values are
indicative of an erythropoietic response to iron supplements, but
not full recovery from IDA. Comparison of the growth rate of P.
falciparum (strains 3D7, Dd2 and FCR3-FMG) within RBCs from
the IDAþ Fe donors to the growth rate of parasites within RBCs
from IR donors revealed increases in P. falciparum growth of
17.3% (s.d.±22.7), 17.6% (s.d.±14.0) and 26.3% (s.d.±16.1) for
3D7, Dd2 and FCR3-FMG in RBCs from IDAþ Fe donors
(Fig. 1b).
We additionally assessed the effect of iron supplementation of
IR individuals on P. falciparum growth. For this study, IR
individuals donated blood at enrollment (baseline) and were then
prescribed daily oral iron supplementation (325mg ferrous
sulfate). Iron-supplemented IR study participants (IRþ Fe)
subsequently returned at one and two months following initiation
of daily iron supplementation to donate blood. At each donation
(enrollment, 1 month and 2 months), the growth rate of
P. falciparum (strains 3D7, Dd2 and FCR3-FMG) within RBCs
from IRþ Fe donors was determined and then compared with the
corresponding parasite growth rates within RBCs from a non-
supplemented IR donor. Compared with RBCs from IR donors,
we observed in RBCs from IRþ Fe donors that 1 month of
iron supplementation increases of 17.5% (s.d.±16.1), 11.3%
(s.d.±15.7) and 6.6% (s.d.±8.1) in growth for 3D7, Dd2 and
FCR3-FMG, respectively. There was no change in parasite growth
rate in RBCs collected 1 and 2 months after administering iron
supplements (Fig. 1c). Analyses of Hgb, haematocrit, MCV,
MCHC, transferrin saturation, ferritin and reticulocyte count of
IRþ Fe donors revealed no signiﬁcant change in their iron status
following iron supplementation (Table 1).
To comprehensively compare and ultimately quantify the
impact of IDA and iron supplementation on the growth of
P. falciparum in vitro, we integrated data from all growth
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Figure 1 | P. falciparum growth is reduced in iron-deﬁcient RBCs and iron supplementation eliminates growth attenuation. (a–c) Growth experiments
with RBCs from IDA donors (n¼ 7), IDAþ Fe donors (n¼ 5) and IRþ Fe donors (n¼4) were performed. Growth rate in RBCs from an IR donor served as
the control. Bars represent growth of P. falciparum (strains 3D7, Dd2 and FCR3-FMG) in indicated RBCs, normalized to growth in RBCs from IR donors (% Pf
growth in IR RBC). Error bars represent the s.d. (a) Bars represent growth in RBCs from IDA donors. Signiﬁcance was determined by two-tailed paired
Student’s t-test. *Po3E 10 as compared with P. falciparum growth in RBCs from IR donors. (b) Bars represent growth in RBCs from IDAþ Fe donors.
Signiﬁcance was determined by two-tailed paired Student’s t-test. *Po0.0003 as compared with P. falciparum growth in RBCs from IR donors. (c) Bars
represent growth of P. falciparum in RBCs from IRþ Fe donors at enrollment, 1 month and 2 months on iron, normalized to growth in RBCs from IR donors
(% Pf growth in IR RBC). Signiﬁcance was determined by one-way analysis of variance. wPo0.02 for strain 3D7and nonsigniﬁcant (n.s.) for strains Dd2 and
FCR3-FMG. (d) Mean growth rate of P. falciparum in RBCs from each individual IDA (&), IRþ Fe (x) and IDAþ Fe (’) donor plotted against the growth
rate of P. falciparum in corresponding control RBCs from non-supplemented IR donors. Data were analysed by mixed effects regression. The Y¼X line was
ﬁt to the growth rates (in RBCs from IR donors). Points below the Y¼X line indicate growth rates less than that within RBCs from IR donors. (e) Graphical
summary of the mixed effects regression analysis shown in d. Donor and parasite preparation were ﬁtted as crossed random effects. The bars show the
estimated parasite growth of P. falciparum in RBCs from the IDA, IDAþ Fe and IRþ Fe donors as a percent of P. falciparum growth in RBCs from non-
supplemented IR donors. Error bars represent the 95% conﬁdence interval.
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experiments and ﬁt a multilevel random effects model to the
pooled data (Fig. 1d). The outputs of this analysis were growth
rates of any parasite strain in experimental RBCs plotted against
the growth rate in IR RBC controls. Values were adjusted for
variation between study participants, day-to-day differences in
parasite preparations and differences in P. falciparum strain
growth rates. The Y¼X line was ﬁt to the growth rate of
P. falciparum in RBCs from IR donors. Data above the Y¼X line
indicate growth rates greater than that of parasite growth in RBCs
from IR donors and data below the Y¼X line indicate growth
rates lower than that of parasite growth RBCs from IR donors.
Based on this analysis, we estimate that compared with IR RBCs,
P. falciparum growth is reduced (59.8% (95% conﬁdence interval
(CI)¼ 51.9–68.8)) in RBCs from IDA donors, and that there is a
slight increase in the growth of P. falciparum in RBCs from
IDAþ Fe donors (22.8% (95% CI¼ 2.7–46.7)) and RBCs from
IRþ Fe donors (18.9% (95% CI¼ 5.0–33.9)); no difference was
observed between P. falciparum growth in RBCs from IRþ Fe
donors and IDAþ Fe donors (Fig. 1e). These data clearly indicate
that IDA substantially attenuates the growth of P. falciparum
parasites and that iron supplementation of donors with IDA
reverses the protection provided by IDA against falciparum
infection. Furthermore, these data suggest that iron supplementa-
tion of IR individuals may slightly increase propagation of
erythrocytic stage P. falciparum.
RBCs from donors with IDA are refractory to malaria infec-
tion. Propagation of the erythrocytic stage of P. falciparum may
be impeded at the point of (i) invasion, (ii) maturation or
(iii) production of infectious daughter merozoites. To determine
why P. falciparum infection of RBCs from IDA donors is reduced,
we systematically assessed the capacity of P. falciparum to pro-
gress through each of these rate-limiting steps within RBCs from
IDA donors compared with RBCs from IR donors. To assess
invasion, we directly compare invasion of P. falciparum strains
3D7, Dd2 and FCR3-FMG into RBCs from IDA and IR donors
with a barcoded RBC ﬂow cytometry based invasion assay. To
express the differential invasion of RBCs, we computed the sus-
ceptibility index (SI), which is the ratio of the relative risk of
IR
IDA
IR
IDA
IR
IDA
3D
7
D
d2
FC
R3
-F
M
G
0.1 1 1.5
Susceptibility index
Invaded less than IR Invaded more than IR
Susceptibility index
(95% confidence interval)
0.99 (0.95 – 1.03)
0.56 (0.56 – 0.57)
0.97 (0.95 – 1.00)
0.52 (0.52 – 0.53)
1.07 (1.02 – 1.12)
0.70 (0.69 – 0.71)
IDA
IR
5 µm
Ring Trophozoite Schizont
120
100
80
60
40
20
0
Pf
 
m
a
tu
ra
tio
n 
st
ag
e
(%
 of
 to
tal
 pa
ras
ite
s)
IDA IR IDA IR IDA IR IDA IR IDA IR IDA IR IDA IR IDA IR IDA IR IDA IR
6 AM 12 PM 6 AM 12 PM 6 AM 12 PM 6 AM 12 PM 6 AM 12 PM
100
80
60
40
20
0
3D
7
Dd
2
FC
R3
-FM
G
PE
M
R
 ID
A 
do
no
r R
BC
s
(%
 IR
 R
BC
 P
EM
R)
*
* *
Ring
Trophozoite
Schizont
a b
c d
Figure 2 | P. falciparum invasion and growth are reduced in RBCs from IDA donors. (a) Direct comparison of invasion into RBCs from either IDA or IR
donors. Invasion experiments for RBCs from all IDA donors were performed independently and each experiment was performed in triplicate. Data show the
mean SI of six independent experiments performed with RBCs from six IDA donors. The marker represents the SI point estimate and the bar represents the
95% CI. An SI of 1.0 indicates no difference in parasite invasion of the two RBC populations. (b,c) Comparison of the maturation of P. falciparum in RBCs
donated by IDA and IR donors. Geimsa-stained thin blood smears were made every 6 h and 1,000 RBCs were counted by light microscopy to determine the
percent of pRBCs as well as parasite intra-erythrocytic stage of maturation. Data are from a representative experiment (with strain FCR3-FMG) of three
independent experiments performed with RBCs from three IDA donors infected with either P. falciparum strain 3D7, Dd2or FCR3. (b) Giemsa-stained thin
blood smears of P. falciparum ring, trophozoite and schizont stage parasites in RBCs from an IDA and an IR donor. (c) Bars indicate percent frequency of
parasite ring, trophozoite and schizont stages in RBCs from an IDA and IR donor at each 6 h time point. Error bars represent the s.d. (d) Comparison of the
parasite erythrocyte multiplication rate (PEMR) of P. falciparum within RBCs from IDA and IR donors. Bars represent PEMR of P. falciparum in RBCs from IDA
donors, normalized to the PEMR of parasites in RBCs from IR donors (% IR PEMR). Data are the mean of three independent experiments performed in
triplicate with RBCs from three IDA donors. Error bars represent the s.d. Signiﬁcance determined by two-tailed paired Student’s t-test.*Po3E 6, compared
with PEMR in RBCs from IR donors.
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invasion of RBCs from IDA donors to that of RBCs from IR
donors. An SI of 1.0 indicates no difference in parasite invasion
between two RBC populations. In experiments with strains 3D7,
Dd2 and FCR3-FMG, the mean SI of RBCs from IDA donors
relative to RBCs from IR donors was 0.56 (95% CI¼ 0.56–0.57),
0.52 (95% CI¼ 0.52–0.53) and 0.70 (95% CI¼ 0.69–0.71),
respectively, indicating consistently reduced invasion of RBCs
from IDA donors (Fig. 2a). We next assessed parasite maturation
within RBCs from IDA donors by analysing Giemsa-stained thing
blood smears, which were made every 6 h during the course of a
48-h intra-erythrocytic lifecycle. We observed that parasites
matured normally in iron-deﬁcient RBCs, indicating that the
reduced overall parasite growth in iron-deﬁcient RBCs did not
result from delayed maturation (Fig 2b,c). Finally, we measured
the parasitized erythrocyte multiplication rate (PEMR)17,18 of P.
falciparum within RBCs from IDA donors as compared with
RBCs from IR donors. For parasite strains 3D7, Dd2 and FCR3-
FMG, RBCs from IDA donors (relative to RBCs from IR donors)
had a reduced PEMR of 48.0% (s.d.±12.2), 25.7% (s.d.±2.2) and
39.9% (s.d.±9.3), respectively (Fig. 2d). In accordance with the
PEMR data, we additionally observed fewer merozoites within
IDA as compared with IR RBCs by microscopy (data not shown).
Taken together, these data indicate that P. falciparum matures
normally within RBCs from IDA donors, but that invasion into
and production of infectious merozoites within RBCs from IDA
donors are signiﬁcantly reduced. These data additionally reveal
that different P. falciparum isolates may exhibit different invasion
and PEMR phenotypes in RBCs of IDA individuals.
Replacement of iron-deﬁcient RBCs increases malaria growth.
The erythropoietic rate of iron-deﬁcient individuals increases
dramatically in response to iron supplementation, and elevated
erythropoietic rate is hypothesized to increase an individual’s
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Figure 3 | Replacement of iron-deﬁcient RBCs with iron-replete RBCs increases P. falciparum infection. (a,b) P. falciparum (strain 3D7) infection of
reticulocytes (CD71þ ) and mature RBCs (CD71 ) from an IDAþ Fe donor. (a) Bars represent the percent of parasitized reticulocytes (CD71þ ) and
mature RBCs (CD71 ). Error bars represent the s.d. *Po0.0001. (b) Contribution of parasitized reticulocytes (CD71þ ) and parasitized mature RBCs
(CD71 ) to the total infection. Error bars represent the standard deviation. (c) Growth rate of P. falciparum in RBC populations in which IDA RBCs were
replaced with IR RBCs. RBCs were inoculated individually or together in the same wells at different ratios (100% IDA; 90% IDA and 10% IR; 75% IDA and
25% IR; 50% IDA and 50% IR; 25% IDA and 75% IR; 100% IR) and subsequently infected. Elongated triangles below the x axis represent the percentage of
IDA RBCs (white triangle) and IR RBCs (grey triangle) in the total RBC population. Bars represent parasite growth rates after one 96 h growth assay. Error
bars represent the s.d. *Po0.01 and **Po0.0003. (d and e) Invasion rate of P. falciparum into RBC populations in which IDA RBCs were replaced with IR
RBCs. Differentially labelled RBC donors were inoculated individually or together in the same wells at different ratios (100% IDA; 90% IDA and 10% IR;
80% IDA and 20% IR; 50% IDA and 50% IR; 20% IDA and 80% IR; 10% IDA and 90% IR; 100% IR). Each invasion condition contained 20 106 total
RBCs. (d) Bars represent parasite invasion rate. Elongated triangles below the x axis represent the percentage of IDA RBCs (white triangle) and IR RBCs
(grey triangle) in the total RBC population. Error bars represent the s.d. *Po0.001, compared with P. falciparum invasion rate into 100% IR RBCs. (e)
Number of invasions events into IDA (diamonds) and IR (circles) RBCs as the frequency of each increases. Linear regression was used to determine the
best ﬁt lines for the data (IR R2¼0.9842 and IDA R2¼0.9305). Analysis of covariance was performed to compare the slopes of the lines and calculated
Po0.0001. The null hypothesis was no difference between the two RBC types (H0: bIron replete¼bIron deﬁcient, a¼0.05) n.s., nonsigniﬁcant.
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susceptibility to malaria19. As the iron biomarkers of individuals
in the IDAþ Fe group were indicative of an erythropoietic
response to iron (Table 1), we hypothesized that the replacement
of iron-deﬁcient RBCs with IR RBCs would explain the recovered
growth of P. falciparum in RBCs from IDAþ Fe donors (Fig. 1).
To determine whether the replacement of iron-deﬁcient RBCs
with young IR RBCs could explain the recovered growth of
P. falciparum in RBCs donated by IDAþ Fe individuals, we ﬁrst
compared P. falciparum infection of reticulocytes (CD71þ ) and
mature RBCs (CD71 ) from IDA þ Fe donors. Consistent with
P. falciparum’s reported preference for young RBCs, we observed
8.6% (s.d.±0.1) parasitization of reticulocytes (CD71þ ) and
4.5% (s.d.±0.4) parasitization of mature RBCs (CD71 )
(Fig. 3a). However, (CD71þ ) reticulocytes accounted for only
1.6% (s.d.±0.9) of all RBCs and parasitized (CD71þ )
reticulocytes only contributed to 3.0% (s.d.±0.1) of the total
number of parasitized RBCs (Fig. 3b).
Having clearly demonstrated that reticulocytes from IDAþ Fe
donors are more highly infected by P. falciparum, but that
reticulocytes themselves only contribute marginally to the total
infection, we next sought to deﬁnitively determine whether the
replacement of iron-deﬁcient with IR RBCs could explain the
recovered growth of P. falciparum in RBCs from IDAþ Fe
donors. However, low incidence of IDA in our study setting, the
difﬁculty of following iron-supplemented IDA individuals
longitudinally through full recovery from iron deﬁciency, as
well as the inability to use the common surrogates of RBC age
(volume and density) against the background of changing
host iron status, prevented us from studying the impact of an
elevated erythropoietic rate on erythrocytic stage P. falciparum
infection. Therefore, we modelled the effect of iron supplementa-
tion-mediated changes in RBC population dynamics on erythro-
cytic stage P. falciparum infection by assessing the impact of
replacing RBCs from IDA donors with RBCs from IR donors on
in vitro P. falciparum growth. Replacing 10, 25, 50 and 75% of the
RBCs from IDA donors with RBCs from IR donors resulted in a
steady increase in parasite growth rate; 75% replacement
recovered 3D7, Dd2 and FCR3-FMG P. falciparum growth rate
to 88.2% (s.d.±2.0), 89.7% (s.d.±2.5) and 92.3% (s.d.±1.1) that
of the growth rate of in RBCs from IR donors, respectively
(Fig. 3c).
As the ﬁrst step in the erythrocytic life cycle of the malaria
parasite, erythrocyte invasion is a pivotal determinant of the
magnitude of infection. Therefore, we utilized the barcoded RBC
invasion assay to determine how iron-deﬁcient and IR RBCs
interact to shape P. falciparum invasion. Like growth rate,
P. falciparum invasion rate increased as IDA RBCs were replaced
with IR RBCs. Rate of invasion was fully recovered to IR levels
once 80% of IDA RBCs were replaced with IR RBCs for all three
parasite strains (Fig. 3d and Supplementary Fig. 2a). Furthermore,
employment of the barcoded RBC invasion assay allowed for the
full characterization of the kinetics of P. falciparum invasion into
IDA and IR RBCs, as the frequency of each changed relative to
the total RBC population. We observed that the number of
P. falciparum FCR3-FMG invasions into IDA and IR RBCs
increased linearly, as each RBC population increased in
frequency, R2¼ 0.984 and 0.931, respectively, and P. falciparum
invasion as a function of IDA RBC abundance was signiﬁcantly
less than that of IR RBCs (Fig. 3e). Similar trends were observed
for P. falciparum strains 3D7 and Dd2 (Supplementary Fig. 2b
and c). Together, these results support the hypothesis that
replacing an individual’s iron-deﬁcient RBC population with IR
RBCs would increase the host’s susceptibility to erythrocytic stage
P. falciparum infection and clearly illustrate the impact RBC
population dynamics have on potential parasite biomass and
pathogenesis. Moreover, our use of the barcoded RBC invasion
assay allowed for the deﬁnitive determination and characteriza-
tion of the distribution of parasites in IDA and IR RBC
populations, as the frequency of each changed.
Effect of RBC population age structure on malaria infection.
Reticulocytes and young RBCs are preferentially invaded by
P. falciparum20,21, and theoretical models predict that elevated
reticulocytosis may increase the risk of high parasite density19,22.
Because of the shortened lifespan of iron-deﬁcient RBCs, there is
a period in the course of an individual’s recovery from IDA at
which point protective iron-deﬁcient RBCs have been cleared
from circulation and the remaining circulating RBCs are on
average younger than that of an IR individual. To determine
the capacity of young RBCs to shape P. falciparum infection, we
(i) directly compare P. falciparum infection of young RBCs and
RBCs of increasing age and (ii) model the effect of replacing
young IR RBCs with old IR RBCs on P. falciparum growth and
invasion in vitro. For these studies, we utilized two proxies for
RBC age: RBC volume, which decreases with age23 and is
unaffected by ring stage parasitization24, and RBC density, which
increases with increasing RBC age23. We observed that when
RBCs from an IR donor were infected with P. falciparum, parasite
infection increased with increasing RBC volume (Fig. 4a). To
directly compare P. falciparum invasion of RBCs of different ages,
we density separated RBCs from IR donors into four fractions of
increasing RBC age: young, young adult, mature adult and old
(Supplementary Fig. 3A). Decreasing MCV, reticulocyte content
and Calcein ﬂuorescence25 conﬁrmed the age separation of the
RBCs (Supplementary Fig. 3b–d). We observed that the SI of
young adult, mature adult and old RBCs to parasite invasion as
compared with young RBCs was 0.85 (95% CI¼ 0.82–0.90), 0.58
(95% CI¼ 0.56–0.62) and 0.28 (95% CI¼ 0.27–0.30), respectively
(Fig. 4b). In accordance with previous reports17,20,26, young RBCs
sustained a signiﬁcantly greater growth rate than young adult,
mature adult and old RBCs, with young RBCs supporting a
growth rate 50% greater than old RBCs (Supplementary Fig. 3e),
and compared with young RBCs the PEMR was reduced by 10%
(s.d.±4.78), 15% (s.d.±1.16) and 19% (s.d.±2.23) in young
adult, mature adult and old RBCs, respectively (Supplementary
Fig. 3f). These data clearly demonstrate the preferential invasion
of P. falciparum into young RBCs and show that the risk of
RBCs to P. falciparum invasion relative to young RBCs
decreases with increasing RBC age. All together we have
conﬁrmed (i) P. falciparum infection is more prevalent in
young RBCs (ii) the increased capacity of young RBCs to
support P. falciparum invasion and growth.
To determine the capacity of the age distribution of a RBC
population to shape P. falciparum infection, we examined the
effect of replacing young IR RBCs with old IR RBCs on
P. falciparum growth in vitro. We observed 15.7% (s.d.±3.1)
greater growth of P. falciparum in young IR RBCs as compared
with density separated and then recombined (total) IR RBCs, and
growth remained signiﬁcantly greater when 10% of young RBCs
were replaced with old RBCs. Following replacement of 33, 50, 66,
80 and 90% of young RBCs with old RBCs, P. falciparum growth
rate steadily decreased (Fig. 4c). Consistent with P. falciparum
growth, we observe that the rate of P. falciparum invasion into
young RBCs is signiﬁcantly greater than that of total IR RBCs
(29.0% (s.d.±2.1)). Furthermore, we observed that as the
frequency of young RBCs decreased from 100 to 50% and the
frequency of old RBCs increased from 0 to 50%, the total rate of
invasion decreased by only 4.9% (s.d.±0.7), maintaining a
P. falciparum invasion rate signiﬁcantly greater than that of the
invasion rate of total RBCs. However, when the frequency of
young RBCs fell from 50 to 0% and old RBCs increased from 50
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to 100%, P. falciparum infection decreased steadily, ultimately
falling by 45.7% (s.d.±1.9) (Fig. 4d).
As young IR RBCs are at the greatest risk of P. falciparum
invasion, we speculated that an insufﬁcient merozoite inoculum
might be responsible for the observed plateau in P. falciparum
invasion. However, invasion experiments with double the
inoculum of merozoites also resulted in a plateau in the rate of
P. falciparum invasion when young RBCs accounted for more
than 50% of the total RBCs population (Supplementary Fig. 4a).
Moreover, the rate of P. falciparum invasion achieved with the
higher inoculum was less than that of the lower inoculum
invasion experiments (Fig. 4d and Supplementary Fig. 4a). We
subsequently characterized the kinetics of P. falciparum invasion
into young and old RBCs as the frequency of each changed
relative to the total RBC population. We observed that like
P. falciparum invasion of IDA and IR RBCs, the number of
P. falciparum invasions into old IR RBCs increased linearly as old
IR RBCs increased in frequency, R2¼ 0.991. In contrast, the
number of P. falciparum invasions into young IR RBCs as a
function of young IR RBC abundance was best ﬁt by a
logarithmic function, R2¼ 0.976 (Fig. 4e). The same kinetics of
P. falciparum invasion were observed when experiments were
performed with double the merozoite inoculum (Supplementary
Fig. 4b). These results demonstrate that replacement of young IR
RBCs with old IR RBCs reverses the elevated growth and invasion
rate sustained by young IR RBCs. In addition, we show that the
rate of P. falciparum invasion only begins to dramatically drop off
once 50% of young IR RBCs have been replaced with old IR
RBCs, and that this can be attributed to the logarithmic nature of
P. falciparum invasion of young IR RBCs. Together, these data
support the hypothesis that the effects of iron deﬁciency and iron
supplementation on RBC physiology and erythropoietic rate are
at least partially responsible for determining an individual’s risk
of malaria infection (Fig. 5).
Discussion
Iron supplementation has clear nutritional beneﬁts for children
and pregnant women2, but iron is also an essential nutrient
for most pathogens and as a result is a critical mediator of
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Figure 4 | The elevated P. falciparum infection supported by young RBCs is reversed as young RBCs are replaced with old RBCs. (a) Percent P.
falciparum (strain 3D7) infection of RBCs of increasing diameter. Data points represent the % pRBCs of ﬁve gated RBC populations of increasing volume.
Error bars represent the s.d. (b) Direct comparison of P. falciparum (strain FCR3-FMG) invasion into RBCs of increasing age. IR RBCs were separated into
ﬁve fractions of increasing density, a proxy for increasing RBC age (Supplementary Fig. 3a–d). The markers represent the SI point estimate and the bar
represents the 95% CI. (c) Growth rate of P. falciparum (strain FCR3-FMG) in RBC populations in which young IR RBCs were replaced with old IR RBCs
(0%, 10%, 20%, 33%, 50%, 66%, 80%, 90% and 100% replacement young RBCs with old RBCs). Elongated triangles represent the percentage of young
IR RBCs (gray triangle) and old IR RBCs (white triangle) in the total RBC population. Bars represent parasite growth rates after 96 h Error bars represent the
s.d. *Po0.004 and **Po0.0003, compared to growth rate in 100% total IR and 100% young RBCs respectively. (d and e) Invasion into RBC populations in
which young IR RBCs were replaced with old IR RBCs. Differentially labelled young and old RBCs were inoculated individually or together in the same wells
at different ratios (0%, 10%, 20%, 33%, 50%, 66%, 80%, 90% and 100% replacement young RBCs with old RBCs). (d) Bars represent invasion rates.
Elongated triangles represent the percentage of young IR RBCs (gray triangle) and old IR RBCs (white triangle) in the total RBC population. Error bars
represent the s.d. *Po0.05 and **Po0.003 (e) Number of invasions events into young (circles) and old (triangles) RBCs as the frequency of each
increases. Linear regression was used to determine best ﬁt lines. A linear function best ﬁt old RBC data (R2¼0.9788) and a logarithmic function best ﬁt
young RBC data (R2¼0.9786). Analysis of covariance was performed to determine whether invasion data of old and young RBCs differed signiﬁcantly,
Po0.0001. The null hypothesis was no difference between the two RBC types (H0: bIron replete¼bIron deﬁcient, a¼0.05) n.s., nonsigniﬁcant.
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host–pathogen interactions27. Activation of the host innate
immune system by the malaria parasite or other infectious
organisms triggers reduction in iron absorption, redistribution of
existing iron stores and decreases erythropoiesis, which effectively
limits the availability of iron to invading pathogens. It is unknown
what host iron (mosquito or human) P. falciparum is able to access
and utilize nor how the parasite circumvents the host’s attempt to
restrict iron. It has been previously postulated that as occurs with
other pathogens28, iron deﬁciency inhibits P. falciparum infection
via iron deprivation. Although the malaria parasite may ﬁnd iron
less readily available in an iron-deﬁcient host, our work reveals an
alternate cellular mechanism by which iron deﬁciency may protect
against malaria. Our study of the relationship between iron
deﬁciency, iron supplementation and erythrocytic stage P.
falciparum infection highlights how by altering the dynamics of
the human hosts RBC population iron deﬁciency and iron
supplementation shape erythrocytic stage P. falciparum infection.
Clinical studies in different ﬁeld sites have reported that iron
deﬁciency correlates with protection from malaria. In Malawian
children, baseline iron deﬁciency was associated with signiﬁcant
reductions in the subsequent risks of both parasitemia (45%) and
malaria (51%)29. Similarly, in Tanzanian children, baseline
iron deﬁciency signiﬁcantly decreased the odds of subsequent
parasitemia (23%) and severe malaria (38%)6. In addition, in two
studies of pregnant women, iron deﬁciency was associated with a
decreased prevalence of placental malaria, a major cause of
neonatal and maternal morbidity3,4. Our results—that iron-
deﬁcient RBCs impair parasite propagation in vitro (Fig. 1)—are
consistent with these clinical ﬁndings, and provide valuable
insight into a cellular mechanism for the observations made in
the clinical setting. In our study of P. falciparum growth in RBCs
from IDA donors, we reveal that RBCs from IDA donors are
refractory to P. falciparum invasion and support a lower PEMR
but that parasite maturation is normal (Fig. 2). There are multiple
physiological differences between iron-deﬁcient and IR RBCs that
may contribute to the impaired invasion into and replication
within iron-deﬁcient RBCs. These include greater osmotic
fragility and membrane rigidity, accelerated ageing in vivo30–33,
lower Hgb content and smaller size (microcytosis).
Iron supplementation has long been hypothesized to increase
malaria risk, and this issue has garnered recent attention after a
large-scale nutritional supplementation study in Tanzanian
children was halted owing to signiﬁcantly increased mortality
among those receiving iron8. Although it remains unclear
whether the increased mortality rate was secondary to malaria,
this potential for harm has complicated recommendations
for widespread supplementation and has caused iron
supplementation programmes in malaria endemic countries to
be suspended. In a more recent randomized trial of Tanzanian
children, iron supplementation increased the risk of malaria by
41% in iron-deﬁcient but not in IR children8. Notably, our studies
are consistent with the Tanzania study. Speciﬁcally, we observed
increased parasite growth in RBCs donated by iron-supplemented
IDA individuals and a modest effect in RBCs donated by
iron-supplemented IR individuals (Fig. 1). As individuals in the
iron-supplemented IDA group were observed to be undergoing
an erythropoietic response to iron supplementation (Table 1), we
proceeded to investigate the effect of replacing iron-deﬁcient
Relative susceptibility to malaria
Microcytic, iron-deficient RBC
Reticulocyte
0 weeks 6 weeks 12 weeks 16 weeks
FeFe Fe
Normal RBC
Figure 5 | Hypothesized impact of iron deﬁciency and iron supplementation on host RBC population dynamics and susceptibility to erythrocytic stage
malaria infection. Recovery from IDA is a complex process, which varies between individuals. Iron supplementation of an individual with IDA (0 weeks) will
result in reticulocytosis and the production of young iron-replete RBCs (6 weeks). 12 weeks after the initiation of supplementation, the majority of the iron-
deﬁcient RBCs, will have been cleared from circulation (iron-deﬁcient and iron-replete RBCs have 90 and 120 day lifespans respectively). After 16 weeks of
iron supplementation, iron status has been corrected and the age structure of the RBC population will be restored. As shown above, we hypothesize that
individuals with IDA will be less susceptible to erythrocytic stage malaria. The induction of erythropoiesis in these individual by iron supplementation and
subsequent replacement of the iron-deﬁcient RBCs with young iron-replete RBCs will increase the susceptibility of the individual to erythrocytic stage
malaria infection. The susceptibility to infection is predicted to peak at the point when all iron-deﬁcient RBCs have been replaced, but the age distribution of
iron-replete RBCs is on average younger than a fully recovered iron-replete individual. Finally, restoration of the normal distribution of RBC age will return an
individual’s susceptibility to a normal level.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5446
8 NATURE COMMUNICATIONS | 5:4446 |DOI: 10.1038/ncomms5446 |www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
RBCs with IR RBCs and young RBCs with old RBCs on
P. falciparum erythrocyte infection. We demonstrate that
P. falciparum growth and invasion rates increase when iron-
deﬁcient RBCs are replaced with IR RBCs (Fig. 3). Furthermore,
we show that young RBCs support greater P. falciparum growth
and invasion rates than total IR RBCs and that the replacement of
young RBCs with old RBCs reverses the effect of young RBCs on
parasite growth and invasion (Fig. 4). Finally, in the course of
these experiments, our use of barcoded RBC ﬂow cytometry
invasion assay has provided novel insight into the relationship
between the frequency of a RBC subset in the total RBC
population and P. falciparum infection (Figs 3e and 4e). In
summary, our results demonstrate that the changes in the RBC
population that occur during recovery from IDA enhance parasite
propagation.
It should be noted that our work exclusively focuses on the
inﬂuence of iron deﬁciency and iron supplementation on the
susceptibility of the human host’s RBC to malaria infection, and
does not address the potential effect of serum iron13 or additional
factors, which may function in vivo, including growth of the
hepatic stage of the parasite34, rosetting and cytoadherence to the
endothelium, accelerated clearance of parasitized RBCs35,36,
effects of innate immune factors such as hepcidin11 and
lipocalin 2 (ref. 37), or adaptive immune function. We have
previously reported that both transferrin and ferric citrate
increase the bioavailable iron pool of trophozoite-infected RBCs
but not that of uninfected RBCs13. It is possible that parasite
growth may be enhanced by the transient increase in serum iron
that is observed in IR individuals who are given oral iron
supplementation12. Further investigations need to be conducted
to explore the extent to which iron deﬁciency and iron
supplementation shape other aspects of malaria pathogenesis.
Our ﬁndings, taken together with those from ﬁeld studies, raise
the important medical and public health question: How can iron
supplementation be safely administered to IDA children in
malarious areas? A critical implication of these observations is
that reconstitution of red cell mass in anaemic patients would be
expected to transiently enhance susceptibility to malaria (Fig. 5),
which may inform the on-going debate as to whether fortiﬁcation
with iron would be safer than supplemental iron. Our data
implies that, where P. falciparum is endemic, treatment of
anaemia with iron supplementation should be accompanied by
malaria preventive measures, such as malaria prophylaxis, bed
nets and increased active surveillance and access to health care.
Additional questions raised by this study are: Does iron deﬁciency
in African children represent an evolutionarily advantageous
phenotype that derives from polymorphisms in iron homeostasis?
What molecular mechanisms confer protection from malaria in
the setting of microcytosis, and can these protective mechanisms
be exploited by medical interventions? Future clinical and
translational studies will be needed in order to design safe and
effective interventions to address the twin burdens of iron
deﬁciency and falciparum malaria.
Methods
Clinical. Study participants included healthy, HIV-negative, non-pregnant donors
over 18 years of age with and without IDA. Exclusion criteria included: on-going
inﬂammation or infection, previous history of malaria, travel to malaria endemic
areas, malignancy, sickle cell disease (or trait), thalassemia (or trait for either
thalassemia-a or -b). This study was approved by the University of North Carolina
Institutional Review Board, Protocol # 09-0559, and informed consent was
obtained from all subjects. Study participants with Hgb 411 g dl 1 and ferritin
412 ngml 1 were classiﬁed as IR and participants with Hgb o11 g dl 1 and
ferritin o12 ngml 1 were classiﬁed as IDA. IDAþ Fe donors were identiﬁed by
their personal physicians for participation in our study. Subjects were included in
the IDAþ Fe group if they ﬁt the criteria for IDA and had been prescribed high-
dose oral ferrous sulfate, 60mg (9–12.6mg kg 1) elemental iron orally three times
per day or intravenous iron at a dosage determined by their personal physician
using the following equation: Dose¼ 0.0442 [desired Hgb observed Hgb]
LBWþ [0.26 LBW]. Healthy donors took 325mg of ferrous sulfate once daily for
the 2-month duration of the study. These donors donated 40ml of blood on three
occasions— at enrollment and two subsequent monthly intervals. An additional
group of healthy donors served as the IR control group. Non-anaemic donors with
low-iron stores (Hgb 411 g dl 1, ferritin o12 ngml 1) were excluded. Full iron
panels were obtained for each study participant and mean values for each group are
reported in Table 1.
Parasite culture. P. falciparum parasite strains 3D7, Dd2 and FCR3-FMG were
cultured in RBCs from Oþ , IR donors at 2–3% haematocrit and Albumax
Complete Media (ACM)–RPMI 1640 (Sigma-Aldrich) with 10% AlbuMAX II
(Gibco), 1mM hypoxanthine (Sigma-Aldrich), 20mM L-glutamine (Cellgro),
0.45% glucose (Cellgro) and 0.01 ngml 1 gentamicin (Sigma-Aldrich). AlbuMAX
II was used to supplement the media in place of human serum to isolate the effects
of the RBCs from different experimental groups. All RBCs used for parasite culture
were obtained from well-characterized IR Oþ donors and used within 14 days of
being drawn. Cultured parasites were maintained between 0.5 and 10% at 37 C, in
an atmosphere of 5% O2, 5% CO2 and 90% N2 with continuous shaking. Early ring
stage parasites were synchronized with 5% (w/v) D-sorbitol. Synchronization was
repeated at 20 and 40 h to achieve a tightly synchronized parasite population.
Growth assay. P. falciparum parasites from routine cultures were seeded as rings
at 0.5% initial parasitemia in 1% haematocrit in ACM in triplicate in 96-well plates.
Parasites were maintained for 96 h under standard culture conditions and the
media was changed daily. At 96 h, parasite cultures were split back to 0.5% para-
sitemia and maintained as described for an additional 96 h (Supplementary Fig. 1).
Parasites were stained at all 0 and 96 h time points with 1 DNA dye SYBR Green
I (Invitrogen) as described in ref. 38, and ﬁxed in 1% paraformaldehyde and
0.0075% glutaraldehyde (Electron Microscopy Sciences) in Alsever’s Solution
(Sigma-Aldrich) for 30min at 4 C. Fixative was removed and cells were stored in
PBS at 4 C until analysis by ﬂow cytometry. Growth rate reﬂects the fold increase
in RBC parasitization between 0 and 96 h. To identify parasitized reticulocytes,
cultures were stained with 0.5 mM DNA dye SYTO 61 (Invitrogen)13,39 and PE-
conjugated mouse anti-human CD71 antibody (Miltenyi Biotech) and analysed by
ﬂow cytometry.
Barcoded RBC invasion assay. RBCs were labelled with 5 mM of either CellTrace
Violet or CellTrace Far Red DDAO-SE (Invitrogen) as described39. Violet- and
DDAO-labelled RBCs were combined in ACM and delivered in triplicate into 96-
well plates and subsequently seeded with schizonts to achieve 1.5–2% parasitized
RBCs. Parasites were maintained for 12–18 h under standard culture conditions to
allow for schizont rupture and subsequent invasion of CellTrace-labelled RBCs.
The invasion of P. falciparum into Violet- and DDAO-labelled RBCs was directly
compared by measuring the SI, deﬁned as the ratio of the prevalences of infected
Violet RBCs to infected DDAO RBCs40. Note that the SI is different from the
previously described selectivity index18,41. The selectivity index has been used to
report the number of multiply infected cells, whereas the SI deﬁnes the relative
susceptibility to invasion of two different types of RBCs.
Parasite erythrocyte multiplication rate assay. Trophozoite-infected cultures
were magnetic activated cell sorting (MACS) puriﬁed and seeded into experimental
RBCs to achieve 1.5–2% pRBCs and incubated for 48 h to allow for invasion of
merozoites into experimental RBCs and their subsequent development into tro-
phozoites inside the experimental RBCs. Experimental RBC parasite density was
determined and the same number of infected experimental RBCs was seeded into
separate wells containing target RBCs (from an IR donor) to achieve 1.5–2%
pRBCs. Cultures were then incubated for 12–18 h to allow merozoites produced
within experimental RBCs to invade target RBCs, allowing for assessment of the
PEMR17,18. Following invasion of target RBCs, cells were stained with SYBR Green
I and analysed by ﬂow cytometry to determine the total number of ring pRBCs.
PEMR reﬂects the number of merozoite invasions of target RBCs per schizont
infected experimental RBC.
Density separation. RBCs were separated into ﬁve fractions with a modiﬁed
version of previously described density gradient centrifugation method23. Brieﬂy,
blood was collected into acid citrate dextrose and plasma was subsequently
removed by centrifugation for 15min at 800g. Packed cells were resuspended at
50% haematocrit in RPMI, and passed over a 2:1 (w/w) a-cellulose/microcrystalline
cellulose column to remove lymphocytes42. Following lymphocyte depletion, RBCs
were washed twice with RBC buffer (10mM HEPES, 12mM NaCl, 115mM KCl,
5% BSA). RBCs were layered onto a 65, 60, 55 and 50% discontinuous Percoll
gradient and then centrifuged for 25min at 1,075 g. Each of the ﬁve fractions was
removed, washed twice with RBC buffer and stored at 4 C for up to 5 days.
Decreasing MCV, reticulocyte content and Calcein ﬂuorescence25 of the ﬁve
fractions conﬁrmed the age separation of RBCs (Supplementary Fig. 3c–g). For
barcoded RBC invasion assays and growth assays, which utilized density separated
RBCs, recombined RBCs were included as a ‘total’ RBC control.
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Flow cytometry. Growth, invasion and infectious merozoite production assays
were analysed by ﬂow cytometry using either a modiﬁed FACS-Calibur with two
lasers 30mW 488 Diode Pumped Solid State laser and a 25-mW 637 red diode
laser (FACS-Calibur; Becton Dickinson, modiﬁed by Cytek Development) or a
Beckman-Coulter (Dako) CyAn ADP. Channels and probes used on the FACS-
Calibur included: SYTO 61 (637 nM, 666/27 bandpass), PE (488 nM, 585/42
bandpass) and SYBR Green I (488 nM, 530/30 bandpass). FACS-Calibur data were
collected using FlowJo CE and analysed with Summit v5.1. Channels and probes
used on the Dako cyan included: CellTrace Violet (405 nM, 450/50 bandpass),
SYBR Green I (488 nM, 530/40 bandpass) and CellTrace DDAO-SE (635 nM,
665/20 bandpass). Data from the Cyan cyotometer were collected and analysed
with Summit v4.3.01. Linear ampliﬁcation of forward scatter was used to set event
threshold in order to exclude cell debris, microparticles and doublets. Electronic
volume of uninfected RBCs and pRBCs was assessed on a Beckman Coulter Cell lab
Quanta (Beckman Coulter). Channels and probes used on the Quanta included:
SYBR Green I (488 nM, 525/40 bandpass). National Institute of Standards and
Technologies-certiﬁed beads standard L2 2 mm, L5 5 mm and L10 10mm (Beckman
Coulter) were used to calibrate electronic volume. Calibrated data were expressed
as both electronic volume (mm3) and diameter (mm). Quanta data were collected
with Cell Lab Quanta Collection Software for Instrument Control and analysed
with Kaluza (Beckman Coulter). For all experiments, samples were diluted to
0.001–0.002% haematocrit and 100,000–500,000 total events were collected.
Statistical methods. All experiments were performed in triplicate. Results are
from either one representative experiment or the combined results of at least
three independent experiments. Parasite growth rate and infectious merozoite
production experiments were analysed with two-tailed Student’s t-test and one-way
analysis of variance (GraphPad Prism 5).
Data from all in vitro growth studies were pooled and analysed using random
effects regression (Fig. 1d,e). The dependent variable in the analysis was the
logarithm of the ratio of the percent pRBCs at 96 h (ﬁnal) and 0 h (initial). In
addition, to the usual variation independently affecting each observation, we ﬁtted
two higher levels of variance: variation between individuals and day-to-day
variation in parasite ‘preparations’ taking account of the fact that in this data set
these two variance components were cross (rather than the more usually
encountered nested design). We ﬁtted two exposure variables, iron status and iron
supplementation, both as binary variables, and their interaction, focusing on three
contrasts: supplemented IDA versus supplemented IR donors; supplemented
versus non-supplemented IDA donors; supplemented versus non-supplemented IR
donors. All experiments were performed in triplicate with three P. falciparum
strains (3D7, Dd2 and FCR3-FMG) and consisted of three serial 96 h growth assays
(Supplementary Fig. 1); P. falciparum strain, growth assay number and their
(highly signiﬁcant) interaction were ﬁtted as binary covariates. We noted that when
0 h (initial) percent pRBCs was greater than 1, the second growth assay always gave
anomalous low results (most likely due to a saturation effect). As these data were
uninformative and yet added noise to the analysis, we omitted all such cases while
noting that although their inclusion increased the standard errors, it did not change
the same general conclusions of the analysis. This model was ﬁtted using Stata’s
xtmixed procedure (v12, Stata Corp).
To compare the susceptibility of different RBC types to invasion by
P. falciparum, an unadjusted odds ratio was used to calculate the SI. All statistical
analyses for invasion experiments were performed with Stata/IC (v10, Stata Corp).
Linear regression was employed to investigate the associations between host iron
status and parasite invasion in vitro using percent of RBCs from IDA or IR donors
as the independent variable and total invasions/1 105 RBCs as the dependent
variable (Fig. 3e). Analysis of covariance was conducted to determine whether the
invasion into the two groups were the same. An a of 0.05 was set a priori to
determine statistically signiﬁcant differences. Similar analysis was done to better
understand associations between RBC age and parasite invasion (Fig. 4e).
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